Skip to content
Numerion Labs logo

Numerion Labs

Numerion Labs is a YC Winter 2015 (W15) company. Based in San Francisco, CA, USA. Team of 67.

  • AI-powered Drug Discovery
  • Deep Learning
  • Biotech
  • Drug discovery
  • Oncology

About Numerion Labs

GPAgent's own fund-neutral profile, written from public information. Updated Oct 4, 2026.

Summary

Numerion Labs builds an AI platform for small-molecule drug discovery, targeting immune and inflammatory diseases. Its machine learning system searches chemical space to identify novel drug-like compounds, replacing the experimental trial-and-error that traditional medicinal and computational chemistry rely on. The platform combines structural biology, computational chemistry, and deep learning to generate and advance internal drug programs.

From the Y Combinator listing

How Numerion Labs describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Artificial intelligence for drug discovery.

Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms. The company unites computational chemistry, structural biology, and medicinal chemistry to pioneer the next generation of AI-driven drug discovery platforms.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
San Francisco, CA, USA
Team size
67
Status
Active
Stage
Growth

Founders (2)

  • Alex Levy
    Founder
  • Izhar Wallach
    Founder

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works